Skip to content

BioXcel Therapeutics, Inc.

Public company
Headquarters
NEW HAVEN, Connecticut
Ticker
BTAIQ
CIK
0001720893

WARN notices since 2024

0
None on record

Workers affected since 2024

0
Across 0 notices

Executive changes, last 12 months

5
1 appointment, 4 departures

Last event

Oct 30, 2026
Executive departureCEO departs: Vimal Mehta, Ph.D.

Workers affected over time

Cumulative workers in WARN notices since 2024

Not enough notices to chart yet.

Leadership

Role and personSinceChange
CEOVimal Mehta, Ph.D.Oct 30, 2026Departed
CFORichard SteinhartOct 30, 2026Departed
Senior Vice President and Chief Scientific OfficerFrank Yocca, Ph.D.Oct 30, 2026Departed
CLOJavier RodriguezOct 30, 2026Departed
President and SecretarySamir SaleemOct 30, 2026Appointed

Related companies

Same industry and state, with recent events.

  1. Executive departure

    CEO departs: Vimal Mehta, Ph.D.

    Vimal Mehta, Ph.D., Chief Executive Officer and President of BioXcel Therapeutics, Inc., leaves the role, effective October 31, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: Chief Executive Officer and President

    Source: SEC 8-K, filed Oct 30, 2026

  2. Executive departure

    CFO departs: Richard Steinhart

    Richard Steinhart, Senior Vice President and Chief Financial Officer of BioXcel Therapeutics, Inc., leaves the role, effective October 31, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: Senior Vice President and Chief Financial Officer

    Source: SEC 8-K, filed Oct 30, 2026

  3. Executive departure

    Senior Vice President and Chief Scientific Officer departs: Frank Yocca, Ph.D.

    Frank Yocca, Ph.D., Senior Vice President and Chief Scientific Officer of BioXcel Therapeutics, Inc., leaves the role, effective October 31, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: Senior Vice President and Chief Scientific Officer

    Source: SEC 8-K, filed Oct 30, 2026

  4. Executive departure

    CLO departs: Javier Rodriguez

    Javier Rodriguez, Senior Vice President, Chief Legal Officer and Corporate Secretary of BioXcel Therapeutics, Inc., leaves the role, effective October 31, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: Senior Vice President, Chief Legal Officer and Corporate Secretary

    Source: SEC 8-K, filed Oct 30, 2026

  5. Executive appointment

    President and Secretary appointed: Samir Saleem

    Samir Saleem was named President and Secretary of BioXcel Therapeutics, Inc., effective October 31, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: President and Secretary

    Source: SEC 8-K, filed Oct 30, 2026

Last verified Nov 8, 2026